PLoS ONE · 2015 · 26 citations · 19 references
This long-term retrospective study indicated that immunosuppressive therapy should be recommended to patients with AA. Also, our experience indicated that immunosuppressive therapy should not be discontinued after response to therapy in patients with both NSAA and SAA due to high risk of relapse. Low dose of CsA should be continued indefinitely.
19
BM Camitta, Thomas Ed, DG Nathan et al. · Blood · 1976 · 554 citations · Full text
Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia
Stephen J. Rosenfeld, Dean Follmann, Olga Núñez et al. · JAMA · 2003 · 394 citations · Full text
Anna Locasciulli, Rosi Oneto, Almalina Bacigalupo et al. · Haematologica · 2007 · 317 citations · Full text